Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/1996
06/11/1996US5525600 Compound useful as antipsychotic, antidepressant and anxiblytic agents
06/11/1996US5525598 Viricides or antitumor agents
06/11/1996US5525596 (r-(r*,r*))-3-((2-hydroxypropyl)amino)-3-methyl-n-2,3,4,5-tet rahydro-2-oxo-1-((2'-(h-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)me thyl-1h-1-benzazepin-3-yl)butanamide, palmitoyl carnitine and cyclodextrin
06/11/1996US5525594 Administering a plant extract oenotheine b to inhibit 5 alpha-reductase
06/11/1996US5525591 Human or veterinary medicine
06/11/1996US5525502 DNA encoding chitin deacetylase
06/11/1996US5525486 Genetic engineering
06/11/1996US5525357 Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
06/11/1996US5525355 Mixture with stool softener
06/11/1996US5525354 Salts of dichloromethylene bisphosphonic acid in drug delivery form with acid-dissolving enteric coating, for oral administration
06/11/1996US5525349 Before and after eye surgery treatment applying a steroid antiinflammatory agent, microbiocides
06/11/1996US5525347 Beta-adrenergic receptor blocking compound and antidiaphoretic compound
06/11/1996US5525341 Partially purified cranberry anti-adhesion activity
06/11/1996US5525339 Presence in circulating bodily fluids provides diagnostic mechanism to determine onset of cerebral amyloid plaque formation
06/11/1996US5525338 Detection and therapy of lesions with biotin/avidin conjugates
06/11/1996US5525334 Method for vascular embolization
06/11/1996US5525330 Antiplaque antigingivitis, anticaries oral composition
06/11/1996US5525329 Inhibition of phosphodiesterase in olfactory mucosa
06/11/1996US5525325 Form metal complexes active as photosensitizers which are stable and water soluble
06/11/1996CA2054664C Hydrolytic stabilizer for unstable organic ions
06/11/1996CA2030397C 1-aryl-1-hydroxy-1-substituted-3-(4-substituted-1- piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders
06/11/1996CA1338377C Stabilized pharmaceutical composition and its production
06/10/1996CA2164559A1 5-methanesulfonamido-6-(2-pyridylthio)-1-indanones as inhibitors of cyclooxygenase-2
06/09/1996CA2164571A1 Aromatically substituted w-amino-alkanoic acid amides and alkanoic acid diamides
06/08/1996CA2164686A1 Antihepatitis agent
06/06/1996WO1996017081A1 Assessment for treatment with neuroleptic agents
06/06/1996WO1996017077A1 Enantioselective preparation of pharmaceutically active sulfoxides by bioreduction
06/06/1996WO1996017076A1 Enantioselective preparation of pharmaceutically active sulfoxides by biooxidation
06/06/1996WO1996017063A1 Plasmids suitable for il-2 expression
06/06/1996WO1996017054A1 Method and compositions for reducing cholesterol absorption
06/06/1996WO1996016991A1 Cationic biopolymers
06/06/1996WO1996016976A1 Antisense oligonucleotide and carcinostatic agent containing the same
06/06/1996WO1996016973A1 Keratan sulfate oligosaccharide fraction and drug containing the same
06/06/1996WO1996016970A1 Substituted 2-(phosphinyloxymethyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
06/06/1996WO1996016967A1 Hindered n-oxide esters of rapamycin and their use as medicaments
06/06/1996WO1996016966A1 Meso-monoiodo-substituted tetramacrocyclic compounds and methods for making and using the same
06/06/1996WO1996016964A1 Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation
06/06/1996WO1996016961A1 (thiophen-2-yl)-piperidin or tetrahydropyridin carboxamides
06/06/1996WO1996016960A1 Quinazoline derivatives
06/06/1996WO1996016955A1 Processes and intermediates for preparing cis(+)3-[4,-6-dihydroxychroman-3-ylmethyl]-4-methoxyaniline
06/06/1996WO1996016952A1 2-substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
06/06/1996WO1996016951A1 Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives and compositions and method of use thereof
06/06/1996WO1996016949A1 Novel 3,5-dioxo-(2h,4h)-1,2,4-triazine derivatives, their preparation and use as drugs
06/06/1996WO1996016940A1 Novel amidinonaphthyl derivative or salt thereof
06/06/1996WO1996016939A1 Perhydroisoindole derivatives as antagonists of substance p
06/06/1996WO1996016938A1 Indole derivative
06/06/1996WO1996016934A1 Substituted biphenyl compounds for the treatment of inflammation
06/06/1996WO1996016931A1 Metalloproteinase inhibitors
06/06/1996WO1996016929A1 Novel multiple-substituent dtpa derivatives and metal complexes thereof, pharmaceutical compositions containing such complexes, their use in diagnosis and therapy, methods of preparing the complexing agents and complexes and methods of preparing the pharmaceutical compositions
06/06/1996WO1996016928A1 Novel substituted dtpa derivatives, their metal complexes, pharmaceutical compositions containing these complexes and their use in diagnosis and therapy
06/06/1996WO1996016680A1 Phosphocholine drug derivatives
06/06/1996WO1996016677A2 Use of metal complexes as liver and gall bladder radiodiagnosis agents in computer tomography
06/06/1996WO1996016675A2 Composition for prevention and treatment of hiv-1 infection comprising at least two different hiv-1 reverse transcriptase inhibitors
06/06/1996WO1996016664A1 Compositions for the treatment of parasitic and fungal infections
06/06/1996WO1996016662A1 Growth factor expression in human pregnant cervix
06/06/1996WO1996016661A2 Use of prostaglandin e1, e2 or analogs to prevent renal failure induced by medical tests that utilize contrast media agents
06/06/1996WO1996016660A1 Combination therapy with estriol and vitamin a, c or e for preventing/treating arterial diseases
06/06/1996WO1996016659A1 Cyclodextrins as suspending agents for pharmaceutical suspensions
06/06/1996WO1996016658A1 Indolocarbazole derivative preparation
06/06/1996WO1996016657A1 Bicyclic heterocyclic compounds for the treatment of impotence
06/06/1996WO1996016654A1 2-(2,3,5,6-tetrafluoro-4-pyridyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
06/06/1996WO1996016653A1 Immunorejection inhibitor
06/06/1996WO1996016652A2 Use of rifabutin and a combination of rifabutin and atovaquone in the treatment of pneumocystis carinii infections
06/06/1996WO1996016651A2 USE OF HALOGENATED β-CARBOLINES AS MODEL SUBSTANCES TO PRODUCE NEURODEGENERATIVE DISORDERS
06/06/1996WO1996016649A1 2-heterocyclyloxy and thiomethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
06/06/1996WO1996016648A1 Method for regulating metalloproteinase activity
06/06/1996WO1996016647A2 Use of chloride channel blockers for reducing intraocular pressure
06/06/1996WO1996016646A1 Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis
06/06/1996WO1996016645A1 Use of nitric oxide donors in medicine
06/06/1996WO1996016644A1 cGMP-PDE INHIBITORS FOR THE TREATMENT OF ERECTILE DYSFUNCTION
06/06/1996WO1996016642A1 Matrix type patch preparation
06/06/1996WO1996016641A1 Transdermal preparation containing a loratidine metabolite with antihistaminic activity
06/06/1996WO1996016640A1 Oral compositions of h2-antagonists
06/06/1996WO1996016639A1 Nsaid delivery employing a powdered hydrocolloid gum obtainable from higher plants
06/06/1996WO1996016634A1 Cosmetic composition
06/06/1996WO1996016632A1 Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof
06/06/1996WO1996016629A2 Phosphinic creatine compounds having antiviral activity
06/06/1996WO1996016542A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5)
06/06/1996WO1995032298A3 Safe vectors for gene therapy
06/06/1996CA2206611A1 Keratan sulfate oligosaccharide fraction and pharmaceutical containing the same
06/06/1996CA2206576A1 Dtpa derivatives substituted in a novel way, their metal complexes, pharmaceutical agents that contain these complexes and their use in diagnosis and therapy
06/06/1996CA2206527A1 Growth factor expression in human pregnant cervix
06/06/1996CA2206526A1 Method and compositions for reducing cholesterol absorption
06/06/1996CA2206522A1 Novel, multiply substituted dtpa derivatives and their metal complexes, pharmaceutical agents that contain these complexes, their use in diagnosis and therapy, as well as process for the production of complexing agents and complexes and process for the production of pharmaceutical agents
06/06/1996CA2206511A1 Compositions for the treatment of parasitic and fungal infections
06/06/1996CA2206422A1 Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis
06/06/1996CA2206397A1 Use of metal complexes as liver and gall bladder x-ray diagnostic agentsin computer tomography
06/06/1996CA2206348A1 Cyclodextrins as suspending agents for pharmaceutical suspensions
06/06/1996CA2206307A1 Indole derivative
06/06/1996CA2206303A1 Matrix type patch formulation
06/06/1996CA2206266A1 Cosmetic composition
06/06/1996CA2206257A1 Substituted biphenyl compounds for the treatment of inflammation
06/06/1996CA2206123A1 Use of chloride channel blockers for reducing intraocular pressure
06/06/1996CA2205972A1 Metalloproteinase inhibitors
06/06/1996CA2205970A1 2-heterocyclyloxy and thiomethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
06/06/1996CA2205950A1 Substituted 2-(phosphinyloxymethyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
06/06/1996CA2205837A1 Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives and compositions and method of use thereof
06/06/1996CA2205800A1 2-(2,3,5,6-tetrafluoro-4-pyridyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
06/06/1996CA2205799A1 2-substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
06/06/1996CA2205584A1 (thiophen-2-yl)-piperidin or tetrahydropyridin carboxamides
1 ... 6910 6911 6912 6913 6914 6915 6916 6917 6918 6919 6920 6921 6922 6923 6924 6925 6926 6927 6928 6929 6930 ... 7860